Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations
Journal Article
·
· Toxicology and Applied Pharmacology
- ToxStrategies, Mission Viejo, CA (United States)
- Summit Toxicology, PO Box 3209, Bozeman, MT 59715 (United States)
A physiologically based pharmacokinetic (PBPK) model for hexavalent chromium [Cr(VI)] in mice, rats, and humans developed previously (Kirman et al., 2012, 2013), was updated to reflect an improved understanding of the toxicokinetics of the gastrointestinal tract following oral exposures. Improvements were made to: (1) the reduction model, which describes the pH-dependent reduction of Cr(VI) to Cr(III) in the gastrointestinal tract under both fasted and fed states; (2) drinking water pattern simulations, to better describe dosimetry in rodents under the conditions of the NTP cancer bioassay; and (3) parameterize the model to characterize potentially sensitive human populations. Important species differences, sources of non-linear toxicokinetics, and human variation are identified and discussed within the context of human health risk assessment. - Highlights: • An improved version of the PBPK model for Cr(VI) toxicokinetics was developed. • The model incorporates data collected to fill important data gaps. • Model predictions for specific age groups and sensitive subpopulations are provided. • Implications to human health risk assessment are discussed.
- OSTI ID:
- 22690987
- Journal Information:
- Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Vol. 325; ISSN TXAPA9; ISSN 0041-008X
- Country of Publication:
- United States
- Language:
- English
Similar Records
An evaluation of in vivo models for toxicokinetics of hexavalent chromium in the stomach
A revised model of ex-vivo reduction of hexavalent chromium in human and rodent gastric juices
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity
Journal Article
·
Tue Sep 15 00:00:00 EDT 2015
· Toxicology and Applied Pharmacology
·
OSTI ID:22465831
A revised model of ex-vivo reduction of hexavalent chromium in human and rodent gastric juices
Journal Article
·
Wed Oct 15 00:00:00 EDT 2014
· Toxicology and Applied Pharmacology
·
OSTI ID:22439882
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity
Journal Article
·
Thu Sep 01 00:00:00 EDT 2016
· Toxicology and Applied Pharmacology
·
OSTI ID:22689258